𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lack of benefit of escalating dosage of interferon alfa in patients with chronic hepatitis C

✍ Scribed by Patrick Marcellin; Michèle Pouteau; Michèle Martinot-Peignoux; Françoise Degos; Véronique Duchatelle; Nathalie Boyer; Catherine Lemonnier; Claude Degott; Serge Erlinger; Jean Pierre Benhamou


Book ID
118881841
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
936 KB
Volume
109
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Re-treatment with interferon alfa of pat
✍ Wan-Cheng Chow; Nathalie Boyer; Michele Pouteau; Corinne Castelnau; Michele Mart 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

Treatment of patients with chronic hepatitis C has had limited success because of relapses and nonresponse to interferon alfa therapy (currently the only established therapeutic agent). A retrospective study was done to determine the efficacy of re-treatment with interferon and the predictors of res

Serum levels of hepatitis C virus core p
✍ E Tanaka; K Kiyosawa; A Matsumoto; T Kashiwakuma; A Hasegawa; H Mori; O Yanagiha 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 2 views

The quantitation of hepatitis C virus (HCV) viremia RNA is measured by molecular techniques such as comcan be helpful in the diagnosis, therapy, and monitoring petitive reverse-transcription polymerase chain reacof patients with chronic hepatitis C. A sensitive and tion and branched DNA (bDNA) signa